HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The CREST syndrome--successful reduction of pulmonary hypertension by captopril.

Abstract
A patient with severe pulmonary hypertension due to pulmonary arteriolar obliteration complicating a long standing CREST variant of systemic sclerosis showed improvement in cardiac output and exercise tolerance during treatment with captopril, which was discontinued because of persistent systemic hypotension. It is suggested that captopril would have a useful and possible prophylactic effect early in pulmonary hypertension in systemic sclerosis.
AuthorsP J Prouse, A Lahiri, J M Gumpel
JournalPostgraduate medical journal (Postgrad Med J) Vol. 60 Issue 708 Pg. 672-4 (Oct 1984) ISSN: 0032-5473 [Print] England
PMID6387690 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Proline
  • Captopril
Topics
  • Captopril (therapeutic use)
  • Female
  • Humans
  • Hypertension, Pulmonary (drug therapy, etiology)
  • Middle Aged
  • Proline (analogs & derivatives)
  • Scleroderma, Systemic (complications)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: